These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10192301)

  • 1. Reproducible scoring of CFU-GM and BFU-E grown in collagen-based semisolid medium after a short (3 h) training.
    Dobo I; Bidet JM; Acquart S; Allegraud A; Amiot L; Boccaccio C; Boiret N; Domenech J; Mossuz P; Sensebe L; Wunder E; Zandecki M; Hermouet S
    J Hematother; 1999 Feb; 8(1):45-51. PubMed ID: 10192301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
    Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
    J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine erythroid (CFU-E, BFU-E) and granulocyte-macrophage colony formation in culture.
    Fritsch G; Nelson RT
    Exp Hematol; 1990 Mar; 18(3):195-200. PubMed ID: 2303113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of collagen for standardization of PBSC graft quality evaluation: a multicenter comparative analysis of commercial collagen-based and methylcellulose-based colony-forming unit (CFU) assay kits.
    Mossuz P; Dobo I; Genevay MC; Allegraud A; Dautel M; Niaussat AE; Cousin F; Praloran V; Boccaccio C; Hermouet S
    J Hematother; 1998 Aug; 7(4):351-9. PubMed ID: 9735866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the precision in CFU-GM and BFU-E counting by flow cytometry-based standardization of short-term culture assays.
    Sheikhzadeh S; Hammers HJ; Hartwig D; Kirchner H; Schlenke P
    J Hematother Stem Cell Res; 2001 Dec; 10(6):881-5. PubMed ID: 11798514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of natural killer cells on modulating CFU-Meg and BFU-E proliferation in situ.
    Pantel K; Nakeff A
    Exp Hematol; 1989 Nov; 17(10):1017-21. PubMed ID: 2806434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS; Casale GP; Watts T
    Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
    Goris H; Bungart B; Loeffler M; Schmitz S; Nijhof W
    Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells.
    Hangoc G; Falkenburg JH; Broxmeyer HE
    Exp Hematol; 1991 Aug; 19(7):697-703. PubMed ID: 1893956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drug-induced hematotoxicity using novel in vitro monkey CFU-GM and BFU-E colony assays.
    Goto K; Goto M; Ando-Imaoka M; Kai K; Mori K
    J Toxicol Sci; 2017; 42(4):397-405. PubMed ID: 28717098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ex vivo expansion of feline marrow cells leads to increased numbers of BFU-E and CFU-GM but a loss of reconstituting ability.
    Abkowitz JL; Taboada MR; Sabo KM; Shelton GH
    Stem Cells; 1998; 16(4):288-93. PubMed ID: 9708451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.